- Home
- AMWL
as 01-21-2025 4:00pm EST
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | Boston |
| Market Cap: | 146.3M | IPO Year: | 2020 |
| Target Price: | $12.50 | AVG Volume (30 days): | 60.7K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.00 - $29.00 | Next Earning Date: | 02-12-2025 |
| Revenue: | $254,035,000 | Revenue Growth: | -5.07% |
| Revenue Growth (this year): | -1.61% | Revenue Growth (next year): | 24.96% |
Stock Insider Trading Activity of American Well Corporation (AMWL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Jan 2 '25 | Sell | $7.17 | 98 | $702.54 | 9,201 | |
| Gotlib Phyllis | AMWL | President, International | Jan 2 '25 | Sell | $7.17 | 1,068 | $7,656.28 | 108,840 | |
| Paunovich Vukasin | AMWL | EVP, Enterprise Platforms | Jan 2 '25 | Sell | $7.17 | 444 | $3,182.95 | 116,121 | |
| Knight Kurt | AMWL | Chief Operating Officer | Dec 4 '24 | Sell | $9.22 | 3,123 | $28,801.56 | 142,213 | |
| Paunovich Vukasin | AMWL | EVP, Enterprise Platforms | Dec 4 '24 | Sell | $9.22 | 3,213 | $29,631.57 | 116,121 | |
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Dec 2 '24 | Sell | $9.22 | 115 | $1,060.58 | 9,201 | |
| Gotlib Phyllis | AMWL | President, International | Dec 2 '24 | Sell | $9.22 | 3,656 | $33,717.09 | 108,840 | |
| Weiler Kathy Johnson | AMWL | Chief Comm. & Growth Officer | Dec 2 '24 | Sell | $9.22 | 7,434 | $68,559.32 | 180,593 | |
| HIRSCHHORN MARK | AMWL | Chief Financial Officer | Nov 4 '24 | Sell | $8.97 | 46,345 | $415,510.73 | 214,382 | |
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Nov 1 '24 | Sell | $8.93 | 9 | $80.37 | 9,201 |
Latest American Well Corporation News
AMWL Breaking Stock News: Dive into AMWL Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
Zacks
8 days ago
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength?
MT Newswires
9 days ago
Wells Fargo Upgrades American Well to Overweight From Equalweight, Price Target is $15
TipRanks
12 days ago
Amwell divests virtual psychiatric care business for $21M and added earn-out
Medical Device Network
13 days ago
Amwell divests virtual psychiatric care business for $21m to boost cash flow
MT Newswires
13 days ago
Amwell Sells Psychiatric Care Unit to Avel eCare for $21 Million
Healthcare Dive
13 days ago
Amwell sells virtual psychiatric care business to Avel eCare for $21M
ACCESSWIRE
13 days ago
Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services
Compare AMWL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMWL American Well Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.